![]() |
5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride |
---|---|
Trade Name | |
Orphan Indication | X-linked adrenoleukodystrophy |
EU Market Approval | EU |
EU Designation Date | 2016-11-18 00:00:00 |
Sponsor | Minoryx Therapeutics S.L. |